Page last updated: 2024-08-24

tirofiban and Hemorrhagic Thrombocythemia

tirofiban has been researched along with Hemorrhagic Thrombocythemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Javed, M; Rahman, MN1
Bildirici, U; Celikyurt, U; Ural, E1
Demir, M; Fareed, J; Gül, C; Iqbal, O; Kürüm, T; Ozbay, G; Vural, O1

Other Studies

3 other study(ies) available for tirofiban and Hemorrhagic Thrombocythemia

ArticleYear
Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia.
    JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:3

    Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Rivaroxaban; Thrombocythemia, Essential; Thrombosis; Tirofiban

2022
Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female.
    Clinical cardiology, 2009, Volume: 32, Issue:2

    Topics: Adult; Age Factors; Antisickling Agents; Aspirin; Clopidogrel; Coronary Angiography; Female; Fibrinolytic Agents; Heparin; Humans; Hydroxyurea; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombocythemia, Essential; Ticlopidine; Tirofiban; Tissue Plasminogen Activator; Tyrosine

2009
Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2004, Volume: 10, Issue:1

    Topics: Female; Humans; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocythemia, Essential; Tirofiban; Treatment Outcome; Tyrosine

2004